Twist Bioscience partners with Miroculus on clinical products

By The Science Advisory Board staff writers

February 25, 2020 -- Synthetic biology company Twist Bioscience announced on February 25 that it has initiated a collaboration with digital microfluidics developer Miroculus for target enrichment and sample library preparation kits.

Twist Bioscience will bring its library preparation and target enrichment next-generation sequencing workflows to Miroculus's Miro Canvas system, a novel automation platform. The goal of the partnership is to streamline experimental processes and offer a wide range of clinical solutions.

LabCorp adopts Thermo Fisher NGS for companion diagnostics
LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine...
A convergence of technologies, revolutionizing next-generation sequencing
A new, powerful combination of biochips and next-generation sequencing (NGS) is capable of solving unique and important biological problems, such as single-cell,...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter